Wu and associates describe in a longitudinal study a reduction in mortality from various causes in the case of resorting to total adrenalectomy in favor of treatment with mineralocorticoid receptor antagonists in monotherapy in patients with unilateral primary aldosteronism [116]. This evidence concerns the gene NR3C2 and primary aldosteronism.